loader

World Tenders & Procurement Opportunities

Search
Advanced Search

693204-Awarded - Portugal – Antineoplastic and immunomodulating agents – 2023/0491 - CANACINUMAB [150 MG/ML SOL INJ FRS]

World Biggest Tenders Source

This tender with title 693204-Awarded - Portugal – Antineoplastic and immunomodulating agents – 2023/0491 - CANACINUMAB [150 MG/ML SOL INJ FRS] has been published on Bidding Source portal dated 22 Oct 2025 for the country of Portugal. It has been categorized on Antineoplastic and immunomodulating agents. For similar tenders you can see tenders mentioned below of this page.

General Information

Portugal

693204-Awarded - Portugal – Antineoplastic and immunomodulating agents – 2023/0491 - CANACINUMAB [150 MG/ML SOL INJ FRS]
Contract Award
693204
Portugal
22 Oct 2025
English
Antineoplastic and immunomodulating agents

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

691045-Awarded - Portugal – Antineoplastic and immunomodulating agents – 2023/0481 - AXICABTAGENE CILOLEUCEL [0.4 - 2 X10E8 CÉLULAS DISPERSÃO INJ SACO] Portugal 691487-Awarded - Portugal – Antineoplastic and immunomodulating agents – 2023/0491 - DURVALUMAB [50 MG/ ML 10 ML FRS] Portugal 691570-Awarded - Portugal – Antineoplastic and immunomodulating agents – 2023/0481 - AXICABTAGENE CILOLEUCEL [0.4 - 2 X10E8 CÉLULAS DISPERSÃO INJ SACO] Portugal 692007-Awarded - Portugal – Antineoplastic and immunomodulating agents – 2023/0491 - OFATUMUMAB [20 MG/0.4 ML SOL INJ CANETA] Portugal 692499-Awarded - Portugal – Antineoplastic and immunomodulating agents – 2023/0491 - BLINATUMOMAB [38.5 µG PÓ CONC SOL SOL INJ FRS] Portugal 692725-Awarded - Portugal – Antineoplastic and immunomodulating agents – 2023/0481 - AXICABTAGENE CILOLEUCEL [0.4 - 2 X10E8 CÉLULAS DISPERSÃO INJ SACO] Portugal 693795-Awarded - Portugal – Antineoplastic and immunomodulating agents – 2023/0491 - LANADELUMAB [300 MG/2 ML SOL INJ SERINGA] Portugal 673065-Awarded - Portugal – Antineoplastic and immunomodulating agents – 2023/0491 - TRASTUZUMAB EMTANSINA [160 MG PÓ CONC SOL INJ FRS] Portugal 673571-Awarded - Portugal – Antineoplastic and immunomodulating agents – 2023/0491 - TRASTUZUMAB EMTANSINA [160 MG PÓ CONC SOL INJ FRS] Portugal 674922-Awarded - Portugal – Antineoplastic and immunomodulating agents – 2023/0491 - TRASTUZUMAB EMTANSINA [160 MG PÓ CONC SOL INJ FRS] Portugal
Antineoplastic and immunomodulating agents Tenders
Portugal Tenders
Europe Tenders
Tenders
No. 12, 1 st floor, Block B2, EGS Business Park, World Trade Center, Bakirkoy - Istanbul - Turkey
info@biddingsource.com
24 X 7 online support
TOP
For viewing latest tenders published for your business in all over the World: Sign in Join free
For accessing full details of Tenders, Kindly choose the Plan that works for you: View Subscription Plans